MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,927,500 | +97.1% | 90,163 | +63.5% | 0.00% | +100.0% |
| Q2 2023 | $1,992,497 | +4.3% | 55,148 | +7.3% | 0.00% | 0.0% |
| Q1 2023 | $1,910,271 | +18.0% | 51,379 | +35.9% | 0.00% | 0.0% |
| Q4 2022 | $1,619,350 | +7.5% | 37,820 | +75.7% | 0.00% | 0.0% |
| Q3 2022 | $1,505,884 | +3.9% | 21,520 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $1,449,019 | -37.6% | 21,551 | -22.8% | 0.00% | -50.0% |
| Q1 2022 | $2,321,223 | -41.3% | 27,902 | +20.8% | 0.00% | -33.3% |
| Q1 2021 | $3,955,000 | -26.7% | 23,089 | -6.0% | 0.00% | -40.0% |
| Q4 2020 | $5,395,000 | +56.1% | 24,565 | +18.0% | 0.01% | +25.0% |
| Q3 2020 | $3,456,000 | +43.2% | 20,816 | -1.1% | 0.00% | +100.0% |
| Q2 2020 | $2,414,000 | +76.6% | 21,049 | +18.3% | 0.00% | 0.0% |
| Q1 2020 | $1,367,000 | -31.9% | 17,789 | +14.2% | 0.00% | 0.0% |
| Q4 2019 | $2,008,000 | +49.7% | 15,581 | -1.9% | 0.00% | 0.0% |
| Q3 2019 | $1,341,000 | -12.1% | 15,886 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $1,526,000 | +55.9% | 14,811 | +10.9% | 0.00% | +100.0% |
| Q1 2019 | $979,000 | +88.6% | 13,357 | +9.1% | 0.00% | 0.0% |
| Q4 2018 | $519,000 | -12.8% | 12,242 | -3.1% | 0.00% | 0.0% |
| Q3 2018 | $595,000 | -7.5% | 12,632 | -3.1% | 0.00% | 0.0% |
| Q2 2018 | $643,000 | +331.5% | 13,040 | +81.3% | 0.00% | – |
| Q1 2016 | $149,000 | -30.4% | 7,194 | +6.6% | 0.00% | – |
| Q4 2015 | $214,000 | -3.2% | 6,751 | +5.2% | 0.00% | – |
| Q3 2015 | $221,000 | +9.4% | 6,420 | 0.0% | 0.00% | – |
| Q2 2015 | $202,000 | +24.7% | 6,420 | +15.6% | 0.00% | – |
| Q1 2015 | $162,000 | +184.2% | 5,552 | +80.5% | 0.00% | – |
| Q4 2014 | $57,000 | -9.5% | 3,076 | -13.9% | 0.00% | – |
| Q3 2014 | $63,000 | -37.6% | 3,574 | -29.5% | 0.00% | – |
| Q2 2014 | $101,000 | – | 5,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |